Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200425047202N1
IRCT20200425047202N1
Completed
Phase 3

The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathy

Shahid Beheshti University of Medical Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChemotherapy induced neuropathy.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Chemotherapy induced neuropathy.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Chemotherapy induced neuropathy in patients treated with taxans or platinums with grade 2 or more of neuropathy

Exclusion Criteria

  • •Lack of cooperation///////
  • •History of neuropathy before chemotherapy
  • •History of allergy to the butulinum toxin
  • •Local infection of the injection places
  • •Rradiculopathy
  • •History of mental disease
  • •Alcolol or substance abuse
  • •Known renal disease
  • •History of miastenia gravis
  • •Use of aminoglycosides

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
The efficacy and safety of subcutaneous injection of bortezomib combined with doxorubicin and dexamethasone for untreated multiple myeloma patients.multiple myeloma
JPRN-UMIN000007803ational Hospital Organization Disaster Medical Center35
Completed
Phase 2
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adultsinfantile paralysispolio10047438
NL-OMON32437ederlands Vaccin Instituut120
Active, not recruiting
Not Applicable
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adults - Intradermal injection of reduced dose IPV in adults
EUCTR2009-015175-27-NLetherlands Vaccine Institute
Not yet recruiting
Phase 1
Assessment of the effect of exosomes in the treatment of melasma
IRCT20221130056672N6Tehran University of Medical Sciences30
Not yet recruiting
Phase 1
Investigating nanofat injection and conditioned medium derived from stem cells in the treatment of androgenic alopeciaHair loss.Nonscarring hair loss, unspecifiedL65.9
IRCT20200127046282N34Tehran University of Medical Sciences10